0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Superconductors Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-0K17844
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Medical Superconductors Market Research Report 2024
BUY CHAPTERS

Global Medical Superconductors Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-0K17844
Report
October 2025
Pages:170
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical Superconductors Market

The global Medical Superconductors market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Magnetic Resonance Imaging accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Medical Superconductors leading manufacturers including Furukawa, Bruker, Luvata, Fujikura, Sumitomo, Western Superconducting, SHSC, Innost, Jastec, SuperPower, etc., dominate supply; the top five capture approximately % of global revenue, with Furukawa leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medical Superconductors market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Medical Superconductors Market Report

Report Metric Details
Report Name Medical Superconductors Market
Segment by Type
Segment by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Furukawa, Bruker, Luvata, Fujikura, Sumitomo, Western Superconducting, SHSC, Innost, Jastec, SuperPower, HORIBA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Medical Superconductors study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Medical Superconductors Market report?

Ans: The main players in the Medical Superconductors Market are Furukawa, Bruker, Luvata, Fujikura, Sumitomo, Western Superconducting, SHSC, Innost, Jastec, SuperPower, HORIBA

What are the Application segmentation covered in the Medical Superconductors Market report?

Ans: The Applications covered in the Medical Superconductors Market report are Magnetic Resonance Imaging, Magnetic Therapy Devices, Magnetoencephalography, Others

What are the Type segmentation covered in the Medical Superconductors Market report?

Ans: The Types covered in the Medical Superconductors Market report are Low Temperature Superconductors, High Temperature Superconductors

Recommended Reports

Superconductor Applications

MRI & Imaging

Cryogenic & Medical

1 Study Coverage
1.1 Introduction to Medical Superconductors: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medical Superconductors Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Low Temperature Superconductors
1.2.3 High Temperature Superconductors
1.3 Market Segmentation by Application
1.3.1 Global Medical Superconductors Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Magnetic Resonance Imaging
1.3.3 Magnetic Therapy Devices
1.3.4 Magnetoencephalography
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Superconductors Revenue Estimates and Forecasts 2020-2031
2.2 Global Medical Superconductors Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Medical Superconductors Sales Estimates and Forecasts 2020-2031
2.4 Global Medical Superconductors Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Medical Superconductors Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Medical Superconductors Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Medical Superconductors Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Low Temperature Superconductors Market Size by Manufacturers
4.5.2 High Temperature Superconductors Market Size by Manufacturers
4.6 Global Medical Superconductors Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Medical Superconductors Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Medical Superconductors Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Medical Superconductors Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Medical Superconductors Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Medical Superconductors Sales and Revenue by Type (2020-2031)
7.4 North America Medical Superconductors Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Medical Superconductors Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Medical Superconductors Sales and Revenue by Type (2020-2031)
8.4 Europe Medical Superconductors Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Medical Superconductors Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Medical Superconductors Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Medical Superconductors Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Medical Superconductors Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Medical Superconductors Sales and Revenue by Type (2020-2031)
10.4 Central and South America Medical Superconductors Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Medical Superconductors Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Medical Superconductors Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Medical Superconductors Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Medical Superconductors Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Furukawa
12.1.1 Furukawa Corporation Information
12.1.2 Furukawa Business Overview
12.1.3 Furukawa Medical Superconductors Product Models, Descriptions and Specifications
12.1.4 Furukawa Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Furukawa Medical Superconductors Sales by Product in 2024
12.1.6 Furukawa Medical Superconductors Sales by Application in 2024
12.1.7 Furukawa Medical Superconductors Sales by Geographic Area in 2024
12.1.8 Furukawa Medical Superconductors SWOT Analysis
12.1.9 Furukawa Recent Developments
12.2 Bruker
12.2.1 Bruker Corporation Information
12.2.2 Bruker Business Overview
12.2.3 Bruker Medical Superconductors Product Models, Descriptions and Specifications
12.2.4 Bruker Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Bruker Medical Superconductors Sales by Product in 2024
12.2.6 Bruker Medical Superconductors Sales by Application in 2024
12.2.7 Bruker Medical Superconductors Sales by Geographic Area in 2024
12.2.8 Bruker Medical Superconductors SWOT Analysis
12.2.9 Bruker Recent Developments
12.3 Luvata
12.3.1 Luvata Corporation Information
12.3.2 Luvata Business Overview
12.3.3 Luvata Medical Superconductors Product Models, Descriptions and Specifications
12.3.4 Luvata Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Luvata Medical Superconductors Sales by Product in 2024
12.3.6 Luvata Medical Superconductors Sales by Application in 2024
12.3.7 Luvata Medical Superconductors Sales by Geographic Area in 2024
12.3.8 Luvata Medical Superconductors SWOT Analysis
12.3.9 Luvata Recent Developments
12.4 Fujikura
12.4.1 Fujikura Corporation Information
12.4.2 Fujikura Business Overview
12.4.3 Fujikura Medical Superconductors Product Models, Descriptions and Specifications
12.4.4 Fujikura Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Fujikura Medical Superconductors Sales by Product in 2024
12.4.6 Fujikura Medical Superconductors Sales by Application in 2024
12.4.7 Fujikura Medical Superconductors Sales by Geographic Area in 2024
12.4.8 Fujikura Medical Superconductors SWOT Analysis
12.4.9 Fujikura Recent Developments
12.5 Sumitomo
12.5.1 Sumitomo Corporation Information
12.5.2 Sumitomo Business Overview
12.5.3 Sumitomo Medical Superconductors Product Models, Descriptions and Specifications
12.5.4 Sumitomo Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Sumitomo Medical Superconductors Sales by Product in 2024
12.5.6 Sumitomo Medical Superconductors Sales by Application in 2024
12.5.7 Sumitomo Medical Superconductors Sales by Geographic Area in 2024
12.5.8 Sumitomo Medical Superconductors SWOT Analysis
12.5.9 Sumitomo Recent Developments
12.6 Western Superconducting
12.6.1 Western Superconducting Corporation Information
12.6.2 Western Superconducting Business Overview
12.6.3 Western Superconducting Medical Superconductors Product Models, Descriptions and Specifications
12.6.4 Western Superconducting Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Western Superconducting Recent Developments
12.7 SHSC
12.7.1 SHSC Corporation Information
12.7.2 SHSC Business Overview
12.7.3 SHSC Medical Superconductors Product Models, Descriptions and Specifications
12.7.4 SHSC Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 SHSC Recent Developments
12.8 Innost
12.8.1 Innost Corporation Information
12.8.2 Innost Business Overview
12.8.3 Innost Medical Superconductors Product Models, Descriptions and Specifications
12.8.4 Innost Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Innost Recent Developments
12.9 Jastec
12.9.1 Jastec Corporation Information
12.9.2 Jastec Business Overview
12.9.3 Jastec Medical Superconductors Product Models, Descriptions and Specifications
12.9.4 Jastec Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Jastec Recent Developments
12.10 SuperPower
12.10.1 SuperPower Corporation Information
12.10.2 SuperPower Business Overview
12.10.3 SuperPower Medical Superconductors Product Models, Descriptions and Specifications
12.10.4 SuperPower Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 SuperPower Recent Developments
12.11 HORIBA
12.11.1 HORIBA Corporation Information
12.11.2 HORIBA Business Overview
12.11.3 HORIBA Medical Superconductors Product Models, Descriptions and Specifications
12.11.4 HORIBA Medical Superconductors Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 HORIBA Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Medical Superconductors Industry Chain
13.2 Medical Superconductors Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Medical Superconductors Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Medical Superconductors Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Medical Superconductors Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Medical Superconductors Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Medical Superconductors Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Medical Superconductors Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Medical Superconductors Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Medical Superconductors Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Medical Superconductors Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Medical Superconductors Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 7. Global Medical Superconductors Sales by Region (2020-2025) & (Kilotons)
 Table 8. Global Medical Superconductors Sales by Region (2026-2031) & (Kilotons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Medical Superconductors Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 11. Global Medical Superconductors Production by Region (2020-2025) & (Kilotons)
 Table 12. Global Medical Superconductors Production by Region (2026-2031) & (Kilotons)
 Table 13. Global Medical Superconductors Sales by Manufacturers (2020-2025) & (Kilotons)
 Table 14. Global Medical Superconductors Sales Share by Manufacturers (2020-2025)
 Table 15. Global Medical Superconductors Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Medical Superconductors Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Medical Superconductors by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Superconductors as of 2024)
 Table 19. Global Medical Superconductors Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Medical Superconductors Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Medical Superconductors Manufacturing Base and Headquarters
 Table 22. Global Medical Superconductors Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Medical Superconductors Sales by Type (2020-2025) & (Kilotons)
 Table 26. Global Medical Superconductors Sales by Type (2026-2031) & (Kilotons)
 Table 27. Global Medical Superconductors Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Medical Superconductors Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Medical Superconductors ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Medical Superconductors Sales by Application (2020-2025) & (Kilotons)
 Table 32. Global Medical Superconductors Sales by Application (2026-2031) & (Kilotons)
 Table 33. Medical Superconductors High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Medical Superconductors Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Medical Superconductors Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Medical Superconductors ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Medical Superconductors Growth Accelerators and Market Barriers
 Table 40. North America Medical Superconductors Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Medical Superconductors Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Medical Superconductors Growth Accelerators and Market Barriers
 Table 43. Europe Medical Superconductors Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Medical Superconductors Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Medical Superconductors Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Medical Superconductors Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Medical Superconductors Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Medical Superconductors Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Medical Superconductors Investment Opportunities and Key Challenges
 Table 50. Central and South America Medical Superconductors Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Medical Superconductors Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Medical Superconductors Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Furukawa Corporation Information
 Table 54. Furukawa Description and Major Businesses
 Table 55. Furukawa Product Models, Descriptions and Specifications
 Table 56. Furukawa Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Furukawa Sales Value Proportion by Product in 2024
 Table 58. Furukawa Sales Value Proportion by Application in 2024
 Table 59. Furukawa Sales Value Proportion by Geographic Area in 2024
 Table 60. Furukawa Medical Superconductors SWOT Analysis
 Table 61. Furukawa Recent Developments
 Table 62. Bruker Corporation Information
 Table 63. Bruker Description and Major Businesses
 Table 64. Bruker Product Models, Descriptions and Specifications
 Table 65. Bruker Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Bruker Sales Value Proportion by Product in 2024
 Table 67. Bruker Sales Value Proportion by Application in 2024
 Table 68. Bruker Sales Value Proportion by Geographic Area in 2024
 Table 69. Bruker Medical Superconductors SWOT Analysis
 Table 70. Bruker Recent Developments
 Table 71. Luvata Corporation Information
 Table 72. Luvata Description and Major Businesses
 Table 73. Luvata Product Models, Descriptions and Specifications
 Table 74. Luvata Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Luvata Sales Value Proportion by Product in 2024
 Table 76. Luvata Sales Value Proportion by Application in 2024
 Table 77. Luvata Sales Value Proportion by Geographic Area in 2024
 Table 78. Luvata Medical Superconductors SWOT Analysis
 Table 79. Luvata Recent Developments
 Table 80. Fujikura Corporation Information
 Table 81. Fujikura Description and Major Businesses
 Table 82. Fujikura Product Models, Descriptions and Specifications
 Table 83. Fujikura Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Fujikura Sales Value Proportion by Product in 2024
 Table 85. Fujikura Sales Value Proportion by Application in 2024
 Table 86. Fujikura Sales Value Proportion by Geographic Area in 2024
 Table 87. Fujikura Medical Superconductors SWOT Analysis
 Table 88. Fujikura Recent Developments
 Table 89. Sumitomo Corporation Information
 Table 90. Sumitomo Description and Major Businesses
 Table 91. Sumitomo Product Models, Descriptions and Specifications
 Table 92. Sumitomo Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Sumitomo Sales Value Proportion by Product in 2024
 Table 94. Sumitomo Sales Value Proportion by Application in 2024
 Table 95. Sumitomo Sales Value Proportion by Geographic Area in 2024
 Table 96. Sumitomo Medical Superconductors SWOT Analysis
 Table 97. Sumitomo Recent Developments
 Table 98. Western Superconducting Corporation Information
 Table 99. Western Superconducting Description and Major Businesses
 Table 100. Western Superconducting Product Models, Descriptions and Specifications
 Table 101. Western Superconducting Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Western Superconducting Recent Developments
 Table 103. SHSC Corporation Information
 Table 104. SHSC Description and Major Businesses
 Table 105. SHSC Product Models, Descriptions and Specifications
 Table 106. SHSC Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. SHSC Recent Developments
 Table 108. Innost Corporation Information
 Table 109. Innost Description and Major Businesses
 Table 110. Innost Product Models, Descriptions and Specifications
 Table 111. Innost Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Innost Recent Developments
 Table 113. Jastec Corporation Information
 Table 114. Jastec Description and Major Businesses
 Table 115. Jastec Product Models, Descriptions and Specifications
 Table 116. Jastec Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Jastec Recent Developments
 Table 118. SuperPower Corporation Information
 Table 119. SuperPower Description and Major Businesses
 Table 120. SuperPower Product Models, Descriptions and Specifications
 Table 121. SuperPower Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. SuperPower Recent Developments
 Table 123. HORIBA Corporation Information
 Table 124. HORIBA Description and Major Businesses
 Table 125. HORIBA Product Models, Descriptions and Specifications
 Table 126. HORIBA Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. HORIBA Recent Developments
 Table 128. Key Raw Materials Distribution
 Table 129. Raw Materials Key Suppliers
 Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 131. Milestones in Production Technology Evolution
 Table 132. Distributors List
 Table 133. Market Trends and Market Evolution
 Table 134. Market Drivers and Opportunities
 Table 135. Market Challenges, Risks, and Restraints
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources


List of Figures
 Figure 1. Medical Superconductors Product Picture
 Figure 2. Global Medical Superconductors Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Low Temperature Superconductors Product Picture
 Figure 4. High Temperature Superconductors Product Picture
 Figure 5. Global Medical Superconductors Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Magnetic Resonance Imaging
 Figure 7. Magnetic Therapy Devices
 Figure 8. Magnetoencephalography
 Figure 9. Others
 Figure 10. Medical Superconductors Report Years Considered
 Figure 11. Global Medical Superconductors Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Medical Superconductors Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Medical Superconductors Revenue Market Share by Region (2020-2031)
 Figure 15. Global Medical Superconductors Sales (2020-2031) & (Kilotons)
 Figure 16. Global Medical Superconductors Sales (CAGR) by Region (2020-2031) (Kilotons)
 Figure 17. Global Medical Superconductors Sales Market Share by Region (2020-2031)
 Figure 18. Global Medical Superconductors Capacity, Production and Utilization (2020-2031) & (Kilotons)
 Figure 19. Global Medical Superconductors Production Trend by Region (2020-2031) (Kilotons)
 Figure 20. Global Medical Superconductors Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. Medical Superconductors Production Growth Rate in North America (2020-2031) & (Kilotons)
 Figure 23. Medical Superconductors Production Growth Rate in Europe (2020-2031) & (Kilotons)
 Figure 24. Medical Superconductors Production Growth Rate in China (2020-2031) & (Kilotons)
 Figure 25. Medical Superconductors Production Growth Rate in Japan (2020-2031) & (Kilotons)
 Figure 26. Top 5 and Top 10 Manufacturers Medical Superconductors Sales Volume Market Share in 2024
 Figure 27. Global Medical Superconductors Revenue Market Share Ranking (2024)
 Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 29. Low Temperature Superconductors Revenue Market Share by Manufacturer in 2024
 Figure 30. High Temperature Superconductors Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 33. Global Medical Superconductors Sales Market Share by Type (2020-2031)
 Figure 34. Global Medical Superconductors Revenue Market Share by Type (2020-2031)
 Figure 35. Global Medical Superconductors Sales Market Share by Application (2020-2031)
 Figure 36. Global Medical Superconductors Revenue Market Share by Application (2020-2031)
 Figure 37. North America Medical Superconductors Sales YoY (2020-2031) & (Kilotons)
 Figure 38. North America Medical Superconductors Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. North America Top 5 Manufacturers Medical Superconductors Sales Revenue (US$ Million) in 2024
 Figure 40. North America Medical Superconductors Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 41. North America Medical Superconductors Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 42. North America Medical Superconductors Sales Volume (Kilotons) by Application (2020-2031)
 Figure 43. North America Medical Superconductors Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. US Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 45. Canada Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 46. Mexico Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 47. Europe Medical Superconductors Sales YoY (2020-2031) & (Kilotons)
 Figure 48. Europe Medical Superconductors Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Europe Top 5 Manufacturers Medical Superconductors Sales Revenue (US$ Million) in 2024
 Figure 50. Europe Medical Superconductors Sales Volume (Kilotons) by Type (2020-2031)
 Figure 51. Europe Medical Superconductors Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Europe Medical Superconductors Sales Volume (Kilotons) by Application (2020-2031)
 Figure 53. Europe Medical Superconductors Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Germany Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 55. France Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 59. Asia-Pacific Medical Superconductors Sales YoY (2020-2031) & (Kilotons)
 Figure 60. Asia-Pacific Medical Superconductors Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Asia-Pacific Top 8 Manufacturers Medical Superconductors Sales Revenue (US$ Million) in 2024
 Figure 62. Asia-Pacific Medical Superconductors Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 63. Asia-Pacific Medical Superconductors Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 64. Asia-Pacific Medical Superconductors Sales Volume (Kilotons) by Application (2020-2031)
 Figure 65. Asia-Pacific Medical Superconductors Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Indonesia Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 67. Japan Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 68. South Korea Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 69. China Taiwan Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 70. India Medical Superconductors Revenue (2020-2031) & (US$ Million)
 Figure 71. Central and South America Medical Superconductors Sales YoY (2020-2031) & (Kilotons)
 Figure 72. Central and South America Medical Superconductors Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Central and South America Top 5 Manufacturers Medical Superconductors Sales Revenue (US$ Million) in 2024
 Figure 74. Central and South America Medical Superconductors Sales Volume (Kilotons) by Type (2021-2031)
 Figure 75. Central and South America Medical Superconductors Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Central and South America Medical Superconductors Sales Volume (Kilotons) by Application (2020-2031)
 Figure 77. Central and South America Medical Superconductors Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. Brazil Medical Superconductors Revenue (2020-2025) & (US$ Million)
 Figure 79. Argentina Medical Superconductors Revenue (2020-2025) & (US$ Million)
 Figure 80. Middle East, and Africa Medical Superconductors Sales YoY (2020-2031) & (Kilotons)
 Figure 81. Middle East and Africa Medical Superconductors Revenue YoY (2020-2031) & (US$ Million)
 Figure 82. Middle East and Africa Top 5 Manufacturers Medical Superconductors Sales Revenue (US$ Million) in 2024
 Figure 83. Middle East and Africa Medical Superconductors Sales Volume (Kilotons) by Type (2021-2031)
 Figure 84. South America Medical Superconductors Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 85. Middle East and Africa Medical Superconductors Sales Volume (Kilotons) by Application (2020-2031)
 Figure 86. Middle East and Africa Medical Superconductors Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 87. GCC Countries Medical Superconductors Revenue (2020-2025) & (US$ Million)
 Figure 88. Turkey Medical Superconductors Revenue (2020-2025) & (US$ Million)
 Figure 89. Egypt Medical Superconductors Revenue (2020-2025) & (US$ Million)
 Figure 90. South Africa Medical Superconductors Revenue (2020-2025) & (US$ Million)
 Figure 91. Medical Superconductors Industry Chain Mapping
 Figure 92. Regional Medical Superconductors Manufacturing Base Distribution (%)
 Figure 93. Medical Superconductors Production Process
 Figure 94. Regional Medical Superconductors Production Cost Structure
 Figure 95. Channels of Distribution (Direct Vs Distribution)
 Figure 96. Bottom-up and Top-down Approaches for This Report
 Figure 97. Data Triangulation
 Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools